Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorSouthern, Kevin
dc.contributor.authorAddy, Charlotte
dc.contributor.authorBell, Scott
dc.contributor.authorBevan, Amanda
dc.contributor.authorBorawska, Urzula
dc.contributor.authorGartner Tizzano, Silvia
dc.contributor.authorBrown, Catherine
dc.date.accessioned2024-04-09T10:13:52Z
dc.date.available2024-04-09T10:13:52Z
dc.date.copyright2023
dc.date.issued2024-01
dc.identifier.citationSouthern K, Addy C, Bell S, Bevan A, Borawska U, Brown C, et al. Standards for the care of people with cystic fibrosis; establishing and maintaining health. J Cyst Fibros. 2024 Jan;23(1):12–28.
dc.identifier.issn1873-5010
dc.identifier.urihttps://hdl.handle.net/11351/11298
dc.descriptionCystic fibrosis; Health; Standards
dc.description.abstractThis is the second in a series of four papers updating the European Cystic Fibrosis Society (ECFS) standards for the care of people with CF. This paper focuses on establishing and maintaining health. The guidance is produced using an evidence-based framework and with wide stakeholder engagement, including people from the CF community. Authors provided a narrative description of their topic and statements, which were more directive. These statements were reviewed by a Delphi exercise, achieving good levels of agreement from a wide group for all statements. This guidance reinforces the importance of a multi-disciplinary CF team, but also describes developing models of care including virtual consultations. The framework for health is reinforced, including the need for a physically active lifestyle and the strict avoidance of all recreational inhalations, including e-cigarettes. Progress with cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy is reviewed, including emerging adverse events and advice for dose reduction and interruption. This paper contains guidance that is pertinent to all people with CF regardless of age and eligibility for and access to modulator therapy.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesJournal of Cystic Fibrosis;23(1)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectFibrosi quística - Tractament
dc.subjectAnomalies cromosòmiques
dc.subjectDecisió de grup
dc.subject.meshMutation
dc.subject.meshDelphi Technique
dc.subject.meshCystic Fibrosis
dc.subject.mesh/therapy
dc.titleStandards for the care of people with cystic fibrosis; establishing and maintaining health
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.jcf.2023.12.002
dc.subject.decsmutación
dc.subject.decstécnica Delfos
dc.subject.decsfibrosis quística
dc.subject.decs/terapia
dc.relation.publishversionhttps://doi.org/10.1016/j.jcf.2023.12.002
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Southern KW] Department of Women's and Children's Health, University of Liverpool, Liverpool, UK. [Addy C] All Wales Adult Cystic Fibrosis Centre, University Hospital Llandough, Cardiff and Vale University Health Board, Cardiff, UK. [Bell SC] Department of Thoracic Medicine and Faculty of Medicine, The University of Queensland, The Prince Charles Hospital, Brisbane, Australia. [Bevan A] University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom. [Borawska U] Institute of Mother and Child in Warsaw, Cystic Fibrosis Department and Dziekanow Lesny Hospital, Cystic Fibrosis Center, Dziekanow Lesny, Poland. [Brown C] West Midlands Adult CF Centre, Heartlands Hospital Birmingham, UK. [Gartner S] Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid38129255
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record